BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17182752)

  • 1. Comparative study of Kaposi's sarcoma-associated herpesvirus serological assays using clinically and serologically defined reference standards and latent class analysis.
    Nascimento MC; de Souza VA; Sumita LM; Freire W; Munoz F; Kim J; Pannuti CS; Mayaud P
    J Clin Microbiol; 2007 Mar; 45(3):715-20. PubMed ID: 17182752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count.
    de Souza VA; Pierrotti LC; Sumita LM; Freire WS; Segurado AA; Pannuti CS
    J Med Virol; 2007 Oct; 79(10):1562-8. PubMed ID: 17705173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of antibodies to Kaposi's sarcoma-associated herpesvirus: a new approach using K8.1 ELISA and a newly developed recombinant LANA ELISA.
    Mbisa GL; Miley W; Gamache CJ; Gillette WK; Esposito D; Hopkins R; Busch MP; Schreiber GB; Little RF; Yarchoan R; Ortiz-Conde BA; Labò N; Whitby D
    J Immunol Methods; 2010 Apr; 356(1-2):39-46. PubMed ID: 20211626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kaposi's sarcoma-associated herpesvirus seroprevalence in selected german patients: evaluation by different test systems.
    Preiser W; Szép NI; Lang D; Doerr HW; Rabenau HF
    Med Microbiol Immunol; 2001 Dec; 190(3):121-7. PubMed ID: 11827200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-1 cells.
    Zhu L; Wang R; Sweat A; Goldstein E; Horvat R; Chandran B
    Virology; 1999 Apr; 256(2):381-92. PubMed ID: 10191203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen.
    Simpson GR; Schulz TF; Whitby D; Cook PM; Boshoff C; Rainbow L; Howard MR; Gao SJ; Bohenzky RA; Simmonds P; Lee C; de Ruiter A; Hatzakis A; Tedder RS; Weller IV; Weiss RA; Moore PS
    Lancet; 1996 Oct; 348(9035):1133-8. PubMed ID: 8888167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of B cell epitopes at the C-terminus of latency-associated nuclear protein of the kaposi's sarcoma-associated herpesvirus.
    Yao S; Tang Q; Cheng L; Zeng Y; Chen X; Qin D; Lv Z; Lu C
    Acta Virol; 2007; 51(2):109-18. PubMed ID: 17900217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human herpesvirus 8 seroconversion in Kenyan women by enzyme-linked immunosorbent assay and immunofluorescence assay.
    Chohan BH; Taylor H; Obrigewitch R; Lavreys L; Richardson BA; Mandaliya KN; Bwayo JJ; Kreiss JK; Morrow RA
    J Clin Virol; 2004 Jun; 30(2):137-44. PubMed ID: 15125869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to human herpesvirus 8 latent and lytic antigens in blood donors and potential high-risk groups in Sweden: variable frequencies found in a multicenter serological study.
    Enbom M; Sheldon J; Lennette E; Schulz T; Ablashi DV; Neipel F; Biberfeld P; Carlberg H; Ljungman P; Nilsson A; Söderström T; Wadström J; Linde A
    J Med Virol; 2000 Dec; 62(4):498-504. PubMed ID: 11074479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective study of Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus in adults with human immunodeficiency virus-1.
    Newton R; Carpenter L; Casabonne D; Beral V; Babiker A; Darbyshire J; Weller I; Weiss R; Kwan A; Bourboulia D; Munoz F; Lagos D; Boshoff C
    Br J Cancer; 2006 May; 94(10):1504-9. PubMed ID: 16705315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma.
    Gao SJ; Kingsley L; Hoover DR; Spira TJ; Rinaldo CR; Saah A; Phair J; Detels R; Parry P; Chang Y; Moore PS
    N Engl J Med; 1996 Jul; 335(4):233-41. PubMed ID: 8657239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in Kaposi's sarcoma-associated Herpesvirus antibodies prior to the development of HIV-associated Kaposi's sarcoma: a nested case-control study.
    Wakeham K; Johnston WT; Nalwoga A; Webb EL; Mayanja BN; Miley W; Elliott AM; Whitby D; Newton R
    Int J Cancer; 2015 Jun; 136(12):2822-30. PubMed ID: 25395177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of antigenic proteins encoded by human herpesvirus 8 and seroprevalence in the general population and among patients with and without Kaposi's sarcoma.
    Katano H; Iwasaki T; Baba N; Terai M; Mori S; Iwamoto A; Kurata T; Sata T
    J Virol; 2000 Apr; 74(8):3478-85. PubMed ID: 10729121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of human herpesvirus-8 infection in HIV-positive patients with and without Kaposi's sarcoma in Hungary.
    Szalai E; Gerlei Z; Szlávik J; Szládek G; Patel R; Hunyadi J; Gergely L; Juhász A
    FEMS Immunol Med Microbiol; 2005 Feb; 43(2):265-8. PubMed ID: 15681157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of whole-virus multiplex luminex-based serological assays for diagnosis of infections with kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 homologs in macaques.
    Ryan JT; Rose TM
    Clin Vaccine Immunol; 2013 Mar; 20(3):409-19. PubMed ID: 23345584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kaposi's sarcoma-associated herpesvirus serology in Europe and Uganda: multicentre study with multiple and novel assays.
    Schatz O; Monini P; Bugarini R; Neipel F; Schulz TF; Andreoni M; Erb P; Eggers M; Haas J; Buttò S; Lukwiya M; Bogner JR; Yaguboglu S; Sheldon J; Sarmati L; Goebel FD; Hintermaier R; Enders G; Regamey N; Wernli M; Stürzl M; Rezza G; Ensoli B
    J Med Virol; 2001 Sep; 65(1):123-32. PubMed ID: 11505454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of serologic assays for detection of antibodies against human herpesvirus 8.
    Corchero JL; Mar EC; Spira TJ; Pellett PE; Inoue N
    Clin Diagn Lab Immunol; 2001 Sep; 8(5):913-21. PubMed ID: 11527803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specifics on the refinement and application of two serological assays for the detection of antibodies to HHV-8.
    Edelman DC; Ketema F; Saville RD; Herman J; Sill AM; Gill PS; Blattner WA; Constantine NT
    J Clin Virol; 2000 May; 16(3):225-37. PubMed ID: 10738141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New immunofluorescence assays for detection of Human herpesvirus 8-specific antibodies.
    Inoue N; Mar EC; Dollard SC; Pau CP; Zheng Q; Pellett PE
    Clin Diagn Lab Immunol; 2000 May; 7(3):427-35. PubMed ID: 10799457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in Kaposi sarcoma-associated herpesvirus-specific and herpesvirus-non-specific immune responses in classic Kaposi sarcoma cases and matched controls in Sicily.
    Amodio E; Goedert JJ; Barozzi P; Riva G; Firenze A; Bonura F; Viviano E; Romano N; Luppi M
    Cancer Sci; 2011 Oct; 102(10):1769-73. PubMed ID: 21740480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.